Mallika Bhat, MD | UniHealth

Offices

4 locations · Integrated Medicine Alliance PA · Telemedicine Group PC · Siskiyou Hospital Inc · Greeley County Health Services Inc

Looking this up.

Hospitals listed: Riverview Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bhat’s office to ask if they take your plan before you enroll.

State licence records

1 licence

New Jersey 25MA09930000Medical Doctor · since 2016 · expires 2027-06-30
ActiveNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Riverview Medical CenterRed Bank, NJAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Hackensack Meridian Health, which runs 13 hospitalsPatients rate it 3 of 5 · 75% would definitely recommend it
Overall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.169, Oct 2024 – Sep 2025

See every measure and the patient survey for Riverview Medical Center

Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 7 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Riverview Medical Center

Clostridium Difficile (C.Diff)Infections	0.169	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	0.72 (0 to 1.62) · 1,474 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	1.08 (0.76 to 1.41)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	162.35 (108.44 to 216.27) · 58 cases	No different	Jul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths	7.1 · 136 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	13.9 · 176 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	9.5 · 561 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	12.8 · 588 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	7.2 · 148 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	3.3 · 1,831 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.15 (0 to 0.36) · 7,610 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.31 (0.12 to 0.5) · 7,859 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	4.6 (2.61 to 6.58) · 1,480 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	1.94 (0.29 to 3.59) · 524 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.48 (0.99 to 3.98) · 1,345 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	10.13 (2.6 to 17.67) · 496 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	7 (3.18 to 10.83) · 503 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.57 (0.13 to 3.02) · 388 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.48 (0 to 1.11) · 6,857 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.7 · 127 cases	None	Apr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0	No different	Oct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.593	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.386	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.623	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	13.9 · 106 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	19.8 · 551 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	7 · 120 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-2 · 621 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	-3.9 · 597 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	17.4 · 519 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	4.7 (3 to 7.1) · 88 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	12.7 (9.1 to 17.4) · 88 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.8 · 106 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20.5 · 125 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.5 (9.5 to 16.4) · 535 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	1 (0.8 to 1.2) · 1,073 cases	No different	Jan 2024 – Dec 2024

What patients said (1,396 patients answered, 21% of those asked)

Sort by

Patient survey stars by topic at Riverview Medical Center

Cleanliness	4
Nurse communication	4
Doctor communication	3
Communication about medicines	3
Discharge information	3
Overall hospital rating	4
Quietness	3
Recommend hospital	4

Sort by

Share of patients giving the best answer at Riverview Medical Center

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	77%
Staff "always" explained	63%
Yes, staff "did" give patients this information	85%
Yes, staff "did" give patients information about help after discharge	86%
Doctors "always" explained things so they could understand	72%
Doctors "always" listened carefully	77%
Doctors "always" treated them with courtesy and respect	83%
Patients who gave a rating of "9" or "10" (high)	74%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	79%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	52%
"YES", patients would definitely recommend the hospital	75%
Staff "always" explained possible side effects	49%
Yes, staff "did" give patients information about possible symptoms	85%

Original Medicare doctor bills

$84,551

Medicare paid this office $84,551 for 372 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	281	$60,806	$101
New patient visit (45+ min)	145	$18,543	$128
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	67	$3,990	$28

Who their Medicare patients are

372 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 11% · Women 63% · Health risk score 1.17. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 75% · Diabetes 62% · Coronary heart disease 37% · Chronic kidney disease 24% · Cancer 18% · Atrial fibrillation 17% · Depression 14% · Heart failure 13% · COPD 11% · Stroke 10% · Dementia 6%.

The office billed $157,328, Medicare allowed $112,862 and paid $84,551; for 908 services of 8 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	372	908	74	1.17	$157,328	$84,551
2023	323	725	73	1.27	$130,748	$68,173
2022	187	308	74	1.00	$57,007	$29,569
2021	174	234	57	1.43	$46,796	$16,092
2020	263	1,516	66	1.55	$81,967	$39,908
2019	209	1,440	70	1.55	$74,764	$37,281
2018	63	135	72	1.50	$19,453	$5,912
2017	124	333	71	1.39	$57,270	$21,410
2016	58	204	71	1.29	$47,831	$11,117
2015	197	353	70	2.26	$74,938	$24,553
2014	427	910	69	1.85	$178,557	$61,977
2013	138	231	68	1.54	$41,592	$14,788

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Sort by

Original Medicare services billed in 2023

Return visit (30+ min)	199	$38,256	$98
New patient visit (45+ min)	191	$24,870	$130
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	43	$2,548	$27
Short return visit (20+ min)	32	$1,964	$58

2022: 6 services

Sort by

Original Medicare services billed in 2022

New patient visit (45+ min)	88	$12,218	$139
Return visit (30+ min)	73	$11,676	$108
Short return visit (20+ min)	22	$1,770	$77
Dxa bone density measurement of hip, pelvis, spine	33	$1,377	$42
New patient visit (30+ min)	14	$1,203	$86
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	21	$840	$28

2021: 3 services

Sort by

Original Medicare services billed in 2021

Short return visit (20+ min)	156	$14,007	$72
New patient visit (30+ min)	18	$1,769	$98
Insertion of needle into vein for collection of blood sample	17	$54	$3

2020: 7 services

Sort by

Original Medicare services billed in 2020

Injection, denosumab, 1 mg	20	$18,540	None
Short return visit (20+ min)	117	$7,541	$64
Return visit (30+ min)	72	$6,387	$78
Telephone medical discussion with physician, 21-30 minutes	32	$2,847	$84
New patient visit (45+ min)	17	$1,986	$117
Telephone medical discussion with physician, 11-20 minutes	22	$1,223	$53
Injection of drug or substance under skin or into muscle	21	$259	$11

2019: 7 services

Sort by

Original Medicare services billed in 2019

Injection, denosumab, 1 mg	19	$16,675	None
Return visit (30+ min)	138	$13,092	$79
New patient visit (45+ min)	27	$3,411	$126
Short return visit (20+ min)	46	$2,285	$50
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin	12	$505	$42
Injection of drug or substance under skin or into muscle	20	$364	$13
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	12	$343	$29

2018: 2 services

Sort by

Original Medicare services billed in 2018

Return visit (30+ min)	47	$4,061	$81
Short return visit (20+ min)	11	$533	$44

2017: 5 services

Sort by

Original Medicare services billed in 2017

Return visit (30+ min)	87	$14,479	$90
New patient visit (45+ min)	30	$4,298	$143
Short return visit (20+ min)	18	$1,240	$62
Blood glucose (sugar) test performed by hand-held instrument	58	$208	$3
Insertion of needle into vein for collection of blood sample	33	$103	$3

2016: 1 service

Sort by

Original Medicare services billed in 2016

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	30	$7,120	$55

2015: 7 services

Sort by

Original Medicare services billed in 2015

Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	35	$6,358	$82
Initial hospital care with moderate level of medical decision making at least 75 minutes	35	$5,748	$155
Return visit (30+ min)	60	$3,497	$57
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	25	$2,524	$101
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	22	$2,261	$55
Short return visit (20+ min)	41	$1,596	$38
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes	15	$1,591	$31

2014: 9 services

Sort by

Original Medicare services billed in 2014

Return visit (30+ min)	179	$20,084	$79
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	117	$11,782	$55
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	94	$10,082	$105
Short return visit (20+ min)	145	$8,416	$47
Initial hospital care with moderate level of medical decision making at least 75 minutes	23	$3,454	$150
New patient visit (45+ min)	19	$2,413	$127
New patient visit (30+ min)	31	$2,394	$77
Initial hospital observation care per day, typically 50 minutes	11	$1,142	$104
Hemoglobin a1c level	43	$598	$13

2013: 6 services

Sort by

Original Medicare services billed in 2013

Return visit (30+ min)	52	$4,269	$82
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	25	$3,079	$54
Initial hospital care with moderate level of medical decision making at least 75 minutes	19	$3,043	$152
Short return visit (20+ min)	41	$2,207	$54
New patient visit (30+ min)	12	$994	$83
Hemoglobin a1c level	40	$514	$13

Medicaid work

$13,707 in 2020

Medicaid paid $13,707 for 115 billed services this clinician did in 2020, up to 84 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2020

Short return visit (20+ min)	115	$13,707

Sort by

Medicaid work by year

2020	115	1	84	$13,707
2018	15	1	15	$881

See the largest Medicaid services in earlier years

2018

Sort by

Largest Medicaid services in 2018

Return visit (30+ min)	15	$881

Drugs they prescribed that Part D paid

$1,278,263

Pharmacies billed $1,278,263 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 2,683) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.

1,053 generic and 1,434 brand-name prescriptions · $1,278,263 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Ozempic	324	$439,455	$1,356
Mounjaro	194	$241,559	$1,245
Jardiance	91	$105,657	$1,161
Trulicity	77	$89,967	$1,168
Tresiba Flextouch U-100	114	$63,756	$559

See all 40 drugs

Sort by

Every Part D drug this clinician prescribed

Ozempic	324	$439,455	$1,356
Mounjaro	194	$241,559	$1,245
Jardiance	91	$105,657	$1,161
Trulicity	77	$89,967	$1,168
Tresiba Flextouch U-100	114	$63,756	$559
Januvia	33	$36,296	$1,100
Fiasp Flextouch	29	$33,969	$1,171
Tresiba Flextouch U-200	24	$25,264	$1,053
Farxiga	26	$23,822	$916
Cinacalcet	27	$20,110	$745
Basaglar Kwikpen U-100	30	$19,935	$664
Lantus Solostar	115	$16,872	$147
Tradjenta	14	$16,786	$1,199
Rybelsus	13	$11,647	$896
Humalog Kwikpen U-100	41	$10,372	$253
Nano 2nd Gen Pen Needle	100	$10,199	$102
Novolog Flexpen	23	$8,484	$369
Synthroid	80	$6,787	$85
Insulin Lispro Kwikpen U-100	12	$3,873	$323
Levemir Flexpen	13	$3,495	$269
Levothyroxine	251	$2,970	$12
Ultra-Fine Nano Pen Needle	26	$2,128	$82
Metformin Hcl Er	113	$1,617	$14
Metformin	153	$1,500	$10
Armour Thyroid	11	$1,464	$133
Repaglinide	57	$1,356	$24
Glipizide Er	77	$937	$12
Ultra-Fine Short Pen Needle	12	$824	$69
Rosuvastatin	27	$662	$25
Methimazole	54	$611	$11
Glimepiride	53	$543	$10
Atorvastatin	37	$436	$12
Liothyronine	13	$371	$29
Simvastatin	26	$304	$12
Pioglitazone	20	$289	$14
Ramipril	12	$200	$17
Losartan	27	$174	$6
Glipizide	29	$129	$4
Alendronate	14	$96	$7
Gabapentin	12	$43	$4

Year by year

Sort by

Part D prescribing by year

2024	2,683	356	0% (0)	53%	$1,278,263
2023	1,405	237	0% (0)	53%	$810,294
2022	428	107	0% (0)	49%	$213,581
2021	1,864	264	0% (0)	31%	$378,562
2020	1,018	264	0% (0)	47%	$413,124
2019	957	208	0% (0)	49%	$422,296
2018	576	95	0% (0)	51%	$264,773
2017	396	85	0% (0)	52%	$203,456
2016	115	37	0% (0)	40%	$31,811
2015	1,106	162	0% (0)	45%	$254,867
2014	2,014	212	0% (0)	43%	$380,273
2013	219	85	0% (0)	40%	$33,884

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 30 drugs

Sort by

Part D drugs prescribed in 2023

Ozempic	120	$189,971	$1,583
Trulicity	100	$145,230	$1,452
Jardiance	61	$72,788	$1,193
Novolog Flexpen	32	$47,078	$1,471
Lantus Solostar	82	$44,024	$537
Tresiba Flextouch U-100	54	$38,980	$722
Mounjaro	27	$37,791	$1,400
Januvia	25	$27,326	$1,093
Tresiba Flextouch U-200	13	$21,278	$1,637
Rybelsus	15	$17,964	$1,198
Humalog Kwikpen U-100	17	$16,199	$953
Cinacalcet	15	$15,510	$1,034
Basaglar Kwikpen U-100	11	$7,585	$690
Nano 2nd Gen Pen Needle	50	$4,614	$92
Synthroid	50	$4,521	$90
Repaglinide	40	$3,426	$86
Levothyroxine	126	$2,408	$19
Ultra-Fine Nano Pen Needle	19	$1,696	$89
Metformin Hcl Er	71	$1,410	$20
Hydrocortisone	13	$1,316	$101
Metformin	85	$944	$11
Pioglitazone	15	$708	$47
Methimazole	24	$625	$26
Ultra-Fine Short Pen Needle	15	$622	$41
Rosuvastatin	12	$605	$50
Glipizide Er	24	$568	$24
Glipizide	21	$342	$16
Glimepiride	30	$230	$8
Atorvastatin	16	$134	$8
Alendronate	11	$117	$11

2022: 12 drugs

Sort by

Part D drugs prescribed in 2022

Trulicity	44	$77,828	$1,769
Jardiance	26	$33,970	$1,307
Tresiba Flextouch U-100	20	$15,986	$799
Novolog Flexpen	15	$13,831	$922
Januvia	16	$13,784	$862
Lantus Solostar	18	$5,532	$307
Repaglinide	25	$1,876	$75
Nano 2nd Gen Pen Needle	19	$1,802	$95
Levothyroxine	40	$752	$19
Metformin Hcl Er	19	$288	$15
Metformin	43	$235	$5
Methimazole	13	$221	$17

2021: 26 drugs

Sort by

Part D drugs prescribed in 2021

Trulicity	66	$68,736	$1,041
Prolia	37	$52,797	$1,427
Januvia	53	$32,996	$623
Jardiance	39	$29,713	$762
Tradjenta	50	$25,877	$518
Testosterone	45	$17,965	$399
Bromocriptine Mesylate	33	$10,182	$309
Testim	11	$6,871	$625
Levothyroxine	453	$6,058	$13
Rosuvastatin	45	$2,035	$45
Metformin	305	$1,776	$6
Atorvastatin	157	$1,712	$11
Tirosint	11	$1,591	$145
Repaglinide	26	$1,551	$60
Acarbose	38	$1,421	$37
Alendronate	81	$1,224	$15
Synthroid	19	$800	$42
Fenofibrate	12	$630	$52
Metformin Hcl Er	52	$502	$10
Pioglitazone	42	$501	$12
Enalapril Maleate	12	$359	$30
Fenofibrate	13	$277	$21
Testosterone Cypionate	13	$275	$21
Pravastatin	18	$252	$14
Methimazole	15	$205	$14
Simvastatin	24	$127	$5

2020: 23 drugs

Sort by

Part D drugs prescribed in 2020

Trulicity	50	$78,245	$1,565
Jardiance	61	$49,777	$816
Lantus Solostar	37	$29,857	$807
Humalog Kwikpen U-100	23	$29,675	$1,290
Novolog Flexpen	20	$20,610	$1,030
Humulin R U-500 Kwikpen	11	$20,134	$1,830
Prolia	14	$18,268	$1,305
Tresiba Flextouch U-100	11	$12,436	$1,131
Januvia	17	$8,274	$487
Novolin N	11	$6,856	$623
Repaglinide	62	$3,511	$57
Ultra-Fine Short Pen Needle	19	$2,879	$152
Levothyroxine	124	$2,219	$18
Hydrocortisone	40	$1,429	$36
Ultra-Fine Nano Pen Needle	16	$1,392	$87
Insulin	12	$963	$80
Cabergoline	12	$922	$77
Metformin Hcl Er	40	$709	$18
Metformin	40	$469	$12
Methimazole	25	$426	$17
Alendronate	44	$397	$9
Atorvastatin	22	$305	$14
Glipizide	15	$90	$6

2019: 29 drugs

Sort by

Part D drugs prescribed in 2019

Trulicity	25	$36,119	$1,445
Lantus Solostar	44	$33,250	$756
Humalog Kwikpen U-100	21	$27,625	$1,315
Novolog Mix 70-30 Flexpen	14	$27,165	$1,940
Jardiance	33	$25,630	$777
Novolog Flexpen	30	$25,104	$837
Humulin R U-500 Kwikpen	14	$24,344	$1,739
Lantus	16	$13,795	$862
Tresiba Flextouch U-100	18	$11,639	$647
Humalog	13	$10,986	$845
Basaglar Kwikpen U-100	19	$9,592	$505
Novolin R	15	$9,520	$635
Novolog	16	$8,764	$548
Novolin N	14	$7,366	$526
Glucagon Emergency Kit	14	$7,259	$519
Novolin 70-30	11	$5,513	$501
Repaglinide	32	$3,477	$109
Ultra-Fine Short Pen Needle	19	$2,608	$137
Levothyroxine	100	$2,098	$21
Ultra-Fine Mini Pen Needle	18	$1,828	$102
Ultra-Fine Nano Pen Needle	13	$1,567	$121
Synthroid	15	$1,307	$87
Hydrocortisone	17	$689	$41
Methimazole	45	$593	$13
Pravastatin	17	$363	$21
Metformin Hcl Er	24	$325	$14
Testosterone Cypionate	12	$320	$27
Metformin	29	$301	$10
Alendronate	33	$289	$9

2018: 20 drugs

Sort by

Part D drugs prescribed in 2018

Victoza 3-Pak	17	$29,309	$1,724
Sensipar	14	$28,340	$2,024
Humalog Kwikpen U-100	28	$27,612	$986
Jardiance	14	$17,400	$1,243
Lantus Solostar	18	$17,272	$960
Trulicity	18	$13,517	$751
Novolog	20	$12,102	$605
Januvia	11	$10,088	$917
Farxiga	14	$9,767	$698
Novolog Flexpen	14	$7,723	$552
Janumet	14	$5,851	$418
Ultra-Fine Nano Pen Needle	20	$1,346	$67
Synthroid	20	$1,259	$63
Repaglinide	17	$1,040	$61
Levothyroxine	35	$789	$23
Glipizide Er	17	$392	$23
Metformin Hcl Er	27	$330	$12
Metformin	27	$184	$7
Glimepiride	19	$159	$8
Losartan	12	$146	$12

2017: 12 drugs

Sort by

Part D drugs prescribed in 2017

Victoza 3-Pak	16	$23,568	$1,473
Jardiance	22	$20,087	$913
Humalog Kwikpen U-100	27	$19,258	$713
Levemir Flextouch	16	$7,971	$498
Lantus Solostar	15	$7,701	$513
Novolin N	13	$1,839	$141
Ultra-Fine Nano Pen Needle	15	$1,061	$71
Levothyroxine	19	$780	$41
Metformin	29	$289	$10
Metformin Hcl Er	15	$214	$14
Glimepiride	14	$193	$14
Methimazole	11	$142	$13

2015: 32 drugs

Sort by

Part D drugs prescribed in 2015

Lantus Solostar	66	$36,591	$554
Novolog Flexpen	32	$17,595	$550
Novolog	30	$17,239	$575
Victoza 3-Pak	19	$15,739	$828
Sensipar	25	$14,324	$573
Humalog Kwikpen U-100	26	$14,138	$544
Januvia	34	$13,778	$405
Tradjenta	26	$13,699	$527
Lantus	20	$11,032	$552
Humalog	14	$10,468	$748
Levemir Flextouch	20	$10,115	$506
Novolog Mix 70-30 Flexpen	15	$7,865	$524
Crestor	16	$5,989	$374
Bd Ultra-Fine Pen Needle	70	$4,528	$65
Invokana	11	$3,711	$337
Cabergoline	18	$2,355	$131
Levothyroxine	89	$1,561	$18
Fenofibrate	24	$1,166	$49
Insulin	18	$726	$40
Metformin Hcl Er	41	$664	$16
Synthroid	13	$648	$50
Glimepiride	35	$577	$16
Valsartan	13	$560	$43
Metformin	50	$533	$11
Fenofibrate	13	$524	$40
Atorvastatin	33	$483	$15
Simvastatin	35	$303	$9
Lisinopril	37	$223	$6
Methimazole	13	$174	$13
Glipizide	22	$164	$7
Hydrochlorothiazide	17	$87	$5
Amlodipine Besylate	14	$77	$5

2014: 47 drugs

Sort by

Part D drugs prescribed in 2014

Lantus Solostar	108	$55,599	$515
Humalog	57	$31,117	$546
Victoza 3-Pak	36	$26,630	$740
Levemir	33	$23,033	$698
Novolog Flexpen	42	$20,858	$497
Lantus	42	$16,942	$403
Januvia	46	$16,330	$355
Sensipar	31	$16,204	$523
Novolog	28	$15,281	$546
Novolog Mix 70-30 Flexpen	31	$15,018	$484
Tradjenta	42	$13,139	$313
Crestor	25	$8,467	$339
Bydureon	11	$8,040	$731
Levemir Flexpen	16	$7,159	$447
Repaglinide	28	$6,529	$233
Levemir Flextouch	11	$6,223	$566
Androgel	14	$5,646	$403
Bd Ultra-Fine Pen Needle	91	$4,804	$53
Janumet	11	$4,466	$406
Metformin Hcl Er	76	$3,228	$42
Levothyroxine	210	$2,934	$14
Humulin N	11	$2,615	$238
Cabergoline	20	$2,343	$117
Fenofibrate	29	$2,228	$77
Nateglinide	16	$1,975	$123
Novolin N	13	$1,330	$102
Novolin R	11	$1,294	$118
Synthroid	31	$1,147	$37
Valsartan	11	$1,123	$102
Metformin	101	$1,076	$11
Atorvastatin	58	$1,056	$18
Fenofibrate	25	$984	$39
Fenofibrate	28	$915	$33
Insulin	22	$816	$37
Liothyronine	26	$721	$28
Glimepiride	51	$656	$13
Simvastatin	65	$646	$10
Lisinopril	78	$634	$8
Insulin	18	$563	$31
Gabapentin	26	$401	$15
Pravastatin	14	$335	$24
Methimazole	13	$230	$18
Glipizide	19	$208	$11
Amlodipine Besylate	29	$142	$5
Alendronate	13	$107	$8
Clopidogrel	12	$94	$8
Hydrochlorothiazide	28	$82	$3

2013: 2 drugs

Sort by

Part D drugs prescribed in 2013

Levothyroxine	22	$300	$14
Simvastatin	13	$112	$9

Money from drug and device companies

$35 in 2025

Sort by

Industry payments by year

2025	1	2	None	$35
2024	2	4	None	$63
2023	1	1	None	$16

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

ViiV Healthcare	Dovato	$35	2 payments Meals for Dovato · 2025-02-04 · $18 Meals for Dovato · 2025-01-13 · $17

See all 2 published payments

Sort by

Every published payment

ViiV Healthcare	Meals · 2025-02-04	Dovato	$18
ViiV Healthcare	Meals · 2025-01-13	Dovato	$17

See earlier years (2024, 2023)

2024: $63

Sort by

Payments by company in 2024

ViiV Healthcare	Dovato	$45	3 payments Meals for Dovato · 2024-09-10 · $15 Meals for Dovato · 2024-04-15 · $16 Meals for Dovato · 2024-01-16 · $15
Ardelyx	Ibsrela	$18	1 payment Meals for Ibsrela · 2024-09-26 · $18

2023: $16

Sort by

Payments by company in 2023

ViiV Healthcare	Dovato	$16	1 payment Meals for Dovato · 2023-09-05 · $16

Professional record

NPI: 1811221807
Licence: NJ 25MA09930000, VA 0101254474New Jersey 25MA09930000: Active
Group: Integrated Medicine Alliance PA · Telemedicine Group PC · Siskiyou Hospital Inc · Greeley County Health Services Inc
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: Yes
Taxonomy: Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
Mailing address: Po Box 8519, Red Bank, NJ, 07701
NPI first listed: 2009-09-24
NPI last updated: 2026-04-09
NPI record certified: 2026-04-09

This is when the NPI record was last certified, not a medical board exam.